Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation September 26, 2026 Breast Cancer
Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin’s Lymphoma September 26, 2026
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors September 26, 2026 Gastrointestinal Cancer
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma September 26, 2026 Lymphoma
Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer September 26, 2026 Cancer Control
Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy September 26, 2026 Genitourinary Cancer
Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) September 26, 2026 Leukemia
Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer September 26, 2026
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia September 26, 2026 Leukemia
Evaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502 September 26, 2026 Cancer Control